Feng Liu

ORCID: 0000-0003-2669-5448
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Catalytic C–H Functionalization Methods
  • Radical Photochemical Reactions
  • Sulfur-Based Synthesis Techniques
  • Synthesis and Catalytic Reactions
  • Fluorine in Organic Chemistry
  • Cancer-related gene regulation
  • Chemical Synthesis and Analysis
  • Epigenetics and DNA Methylation
  • Oxidative Organic Chemistry Reactions
  • Catalytic Cross-Coupling Reactions
  • Nanoparticle-Based Drug Delivery
  • RNA Interference and Gene Delivery
  • Asymmetric Hydrogenation and Catalysis
  • Synthetic Organic Chemistry Methods
  • Chemical Synthesis and Reactions
  • Cyclopropane Reaction Mechanisms
  • Asymmetric Synthesis and Catalysis
  • Carbohydrate Chemistry and Synthesis
  • Enzyme Catalysis and Immobilization
  • Glycosylation and Glycoproteins Research
  • Drug Transport and Resistance Mechanisms
  • Cancer therapeutics and mechanisms
  • Inflammasome and immune disorders
  • Catalytic Alkyne Reactions
  • RNA modifications and cancer

Soochow University
2016-2025

Kunming Institute of Precious Metals
2023-2025

Central South University
2009-2025

Hunan University
2022-2025

State Key Laboratory of Chemobiosensing and Chemometrics
2025

Tsinghua–Berkeley Shenzhen Institute
2025

Second Xiangya Hospital of Central South University
2025

Buchang Pharma (China)
2022-2025

Xi'an Jiaotong University
2011-2025

Shaanxi Institute of International Trade & Commerce
2022-2025

EZH2 or EZH1 is the catalytic subunit of polycomb repressive complex 2 that catalyzes methylation histone H3 lysine 27 (H3K27). The trimethylation H3K27 (H3K27me3) a transcriptionally post-translational modification. Overexpression and hypertrimethylation have been implicated in number cancers. Several selective inhibitors reported recently. Herein we disclose UNC1999, first orally bioavailable inhibitor has high vitro potency for wild-type mutant as well EZH1, closely related...

10.1021/cb400133j article EN ACS Chemical Biology 2013-04-08

Among epigenetic "writers", "readers", and "erasers", the lysine methyltransferases G9a GLP, which catalyze mono- dimethylation of histone H3 9 (H3K9me2) nonhistone proteins, have been implicated in a variety human diseases. A "toolkit" well-characterized chemical probes will allow biological disease hypotheses concerning these proteins to be tested cell-based animal models with high confidence. We previously discovered potent selective G9a/GLP inhibitors including cellular probe UNC0638,...

10.1021/jm401480r article EN Journal of Medicinal Chemistry 2013-10-08

Cerebral ischemia–reperfusion injury (CIRI), a cause of cerebral dysfunction during infarction treatment, is closely associated with mitochondrial viscosity and hydrogen peroxide (H2O2). However, the accurate measurement H2O2 levels in CIRI challenging because lack sufficient selectivity blood–brain barrier (BBB) penetration existing monitoring tools related to CIRI, hampering exploration role CIRI. To address this issue, we designed an activatable fluorescent probe, mitochondria-targeting...

10.1021/acs.analchem.3c04781 article EN Analytical Chemistry 2024-02-19

SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template led to discovery 8 (UNC0224) as a potent and selective G9a inhibitor. A high resolution X-ray crystal structure G9a-8 complex, first cocrystal with small molecule inhibitor, was obtained. The validated our binding hypothesis will enable structure-based design novel inhibitors. is useful tool for investigating biology its roles in chromatin remodeling.

10.1021/jm901543m article EN Journal of Medicinal Chemistry 2009-11-05

Protein lysine methyltransferase G9a, which catalyzes methylation of 9 histone H3 (H3K9) and 373 (K373) p53, is overexpressed in human cancers. Genetic knockdown G9a inhibits cancer cell growth, the dimethylation p53 K373 results inactivation p53. Initial SAR exploration 2,4-diamino-6,7-dimethoxyquinazoline template represented by 3a (BIX01294), a selective small molecule inhibitor GLP, led to discovery 10 (UNC0224) as potent with excellent selectivity. A high resolution X-ray crystal...

10.1021/jm100478y article EN Journal of Medicinal Chemistry 2010-07-09

Here we described a paclitaxel (PTX) nanocrystal formulation using d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) as the sole excipient for overcoming multidrug resistance (MDR), key challenge in current cancer therapy. To best of our knowledge, it is first report on PTX nanocrystals which can reverse MDR. TPGS serves surfactant to stabilize and P-gp inhibitor The size morphology were studied by transmission electron microscopy, crystalline structure was determined powder X-ray...

10.1021/mp100012s article EN Molecular Pharmaceutics 2010-04-26

Protein lysine methyltransferase G9a plays key roles in the transcriptional repression of a variety genes via dimethylation 9 on histone H3 (H3K9me2) chromatin as well nonhistone proteins including tumor suppressor p53. We previously reported discovery UNC0321 (3), most potent inhibitor to date, structure-based design and structure-activity relationship (SAR) exploration quinazoline scaffold represented by BIX01294 (1). Despite its very high vitro potency, compound 3 lacks sufficient...

10.1021/jm200903z article EN Journal of Medicinal Chemistry 2011-07-22

Chromatin modulators are emerging as attractive drug targets, given their widespread implication in human cancers and susceptibility to pharmacological inhibition. Here we establish the histone methyltransferase G9a/EHMT2 a selective regulator of fast proliferating myeloid progenitors with no discernible function hematopoietic stem cells (HSCs). In mouse models acute leukemia (AML), loss G9a significantly delays disease progression reduces cell (LSC) frequency. We connect this its activity...

10.1101/gad.236794.113 article EN Genes & Development 2014-02-14

10.1016/j.ijpharm.2010.02.013 article EN International Journal of Pharmaceutics 2010-02-22

Targeted delivery remains the major challenge for application of small interfering RNA (siRNA). We have developed a lipid/calcium/phosphate (LCP) nanoparticle (NP) to improve siRNA efficiency. The LCP NP was prepared by using microemulsion technology form calcium/phosphate (CaP) core and further coated with cationic lipids. final grafted polyethylene glycol (PEG) anisamide (AA) ligand on surface target sigma receptor-expressing B16F10 melanoma cells. exhibited 40 nm particle size, +25 mV...

10.1038/mt.2011.270 article EN cc-by-nc-nd Molecular Therapy 2011-12-20

Copper-catalyzed direct conversion of benzylic alcohols to aryl nitriles was realized using NH3(aq.) as the nitrogen source, O2 oxidant and TEMPO co-catalyst. Furthermore, copper-catalyzed one-pot synthesis primary amides from also achieved.

10.1039/c3ob00002h article EN Organic & Biomolecular Chemistry 2013-01-01

Multifunctional membrane-core nanoparticles, composed of calcium phosphate cores, arginine-rich peptides, cationic and PEGylated lipid membranes, galactose targeting ligands, have been developed as synthetic vectors for efficient nuclear delivery plasmid DNA subsequent gene expression in hepatocytes vivo. Targeted particles exhibited rapid extensive hepatic accumulation were predominantly internalized by hepatocytes, while the inclusion such peptides LCP was sufficient to elicit high degrees...

10.1021/nn4012384 article EN ACS Nano 2013-05-07

A convenient and practical protocol is developed for radical vicinal difunctionalization of unactivated alkenes under transition-metal-free conditions.

10.1039/c7cc01903c article EN Chemical Communications 2017-01-01

The key property of protein–nanoparticle conjugates is the bioactivity protein. ability to accurately modulate activity protein on nanoparticles at interfaces important in many applications. In work reported here, modulation protein–gold nanoparticle (AuNP) by specifically orienting and varying surface density was investigated. Different orientations were achieved introducing cysteine (Cys) residues specific sites for binding gold. We chose Escherichia coli inorganic pyrophosphatase (PPase)...

10.1021/am5084545 article EN ACS Applied Materials & Interfaces 2015-01-26

A redox-neutral, mild, and simple protocol is developed for the synthesis of α-trifluoromethylated ketones from vinyl azides upon visible-light irradiation.

10.1039/c6cc10035j article EN Chemical Communications 2017-01-01

A mild and simple protocol is developed for the synthesis of terminal alkenes <italic>via</italic> site-specific C–C bond formation upon visible-light irradiation.

10.1039/c8qo01046c article EN Organic Chemistry Frontiers 2018-01-01

Minimizing energy loss is crucial for breaking through the efficiency bottleneck of organic solar cells (OSCs). The main mechanism can be attributed to non-radiative recombination (ΔEnr) that occurs due exciton-vibration coupling. To tackle this challenge, tuning intramolecular noncovalent interactions strategically utilized tailor novel fused ring electron acceptors (FREAs). Upon comprehensive analysis both theoretical and experimental results, approach effectively enhance molecular...

10.1002/anie.202418926 article EN Angewandte Chemie International Edition 2024-12-03
Coming Soon ...